SI-BONE/SIBN

$17.59

-14.36%
-
1D1W1MYTD1YMAX

About SI-BONE

SI-BONE, Inc. is a medical device company. The Company is engaged in solving musculoskeletal disorders of the sacropelvic anatomy. The Company's products include a series of patented titanium implants and the instruments used to implant them. It offers iFuse, iFuse-3D, and iFuse-TORQ implant systems. iFuse is a machined triangular titanium implant that has a triangular cross-section that resists twisting or rotation of the implant. iFuse-3D implants are used for the fusion of the sacroiliac joint in conjunction with multi-level spinal fusion procedures to provide further stabilization and immobilization of the sacroiliac joint. iFuse-TORQ is a line of three-dimensional (3D)-printed threaded implants designed for use in pelvic trauma, as well as applications in sacroiliac joint dysfunction and degeneration. The Company also holds patents for the method of placing the implant across the sacroiliac joint, as well as other parts of the spine and pelvis.

Ticker

SIBN

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Jeffrey Dunn

Employees

357

Headquarters

Santa clara, United States

SI-BONE Metrics

BasicAdvanced
$820.96M
Market cap
-
P/E ratio
-$1.19
EPS
1.24
Beta
-
Dividend rate

What the Analysts think about SI-BONE

Analyst Ratings

Majority rating from 8 analysts.
Buy

Price Targets

Average projection from 8 analysts.
52.81% upside
High $32.00
Low $24.00
$17.59
Current price
$26.88
Average price target

SI-BONE Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-29.41% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$34M
2.1%
Net income
$-10M
-10.71%
Profit margin
-29.41%
-12.55%

SI-BONE Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.44%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.32
-$0.30
-$0.25
-$0.27
-
Expected
-$0.41
-$0.40
-$0.34
-$0.28
-$0.26
Surprise
-21.87%
-24.36%
-27.06%
-3.44%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell SI-BONE stock

Buy or sell SI-BONE stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing